Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy episode artwork

EPISODE · Nov 8, 2024 · 17 MIN

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

from PeerVoice Internal Medicine Audio · host PeerVoice

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

Visit https://www.peervoice.com/CZH860 to view the entire programme with slides. After completing “Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy”, participants will be able to: Distinguish between the clinical trials examining new and emerging therapies in IgA nephropathy (IgAN); Recognize the mechanistic rationale for targeting the drivers of immunopathogenesis in IgAN; and Evaluate clinical evidence and data regarding emerging therapies in patients with IgAN.

NOW PLAYING

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

0:00 17:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of PeerVoice Internal Medicine Audio?

This episode is 17 minutes long.

When was this PeerVoice Internal Medicine Audio episode published?

This episode was published on November 8, 2024.

What is this episode about?

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

Can I download this PeerVoice Internal Medicine Audio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!